FTSE All-Share
5.255,86
PKT
-11,04
PKT
-0,21
%
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 06.01.12 | Marks Spencer sell | ING | |
| 06.01.12 | J. Sainsbury neutral | Nomura | |
| 06.01.12 | Wm Morrison Supermarkets buy | Nomura | |
| 06.01.12 | Vodafone Group kaufen | Raiffeisen Centrobank AG | |
| 05.01.12 | GSK neutral | J.P. Morgan Cazenove | |
| 05.01.12 | Vodafone Group outperform | Macquarie Research | |
| 05.01.12 | Sky buy | Nomura | |
| 05.01.12 | Unilever halten | Independent Research GmbH | |
| 05.01.12 | Next hold | Société Générale Group S.A. (SG) | |
| 05.01.12 | Anglo American overweight | Barclays Capital | |
| 04.01.12 | Glencore buy | Deutsche Bank AG | |
| 04.01.12 | Rio Tinto buy | UBS AG | |
| 04.01.12 | Marks Spencer hold | Société Générale Group S.A. (SG) | |
| 04.01.12 | Intertek buy | Sarasin Research | |
| 03.01.12 | Shell (ex Royal Dutch Shell) buy | Société Générale Group S.A. (SG) | |
| 03.01.12 | Sky buy | Royal Bank of Scotland | |
| 03.01.12 | Pearson outperform | Credit Suisse Group | |
| 03.01.12 | Barclays buy | Citigroup Corp. | |
| 03.01.12 | Diageo hold | ING | |
| 03.01.12 | Smith Nephew buy | Société Générale Group S.A. (SG) | |
| 27.12.11 | Shell (ex Royal Dutch Shell) halten | Raiffeisen Centrobank AG | |
| 23.12.11 | Barclays sell | Goldman Sachs Group Inc. | |
| 23.12.11 | GSK verkaufen | Hamburger Sparkasse AG (Haspa) | |
| 22.12.11 | Marks Spencer neutral | Credit Suisse Group | |
| 22.12.11 | Vodafone Group outperform | Sanford C. Bernstein and Co., Inc. | |
| 22.12.11 | Hays neutral | Goldman Sachs Group Inc. | |
| 22.12.11 | Glencore outperform | Credit Suisse Group | |
| 22.12.11 | Anglo American buy | UBS AG | |
| 22.12.11 | AstraZeneca halten | Independent Research GmbH | |
| 22.12.11 | GSK neutral | Goldman Sachs Group Inc. | |
| 21.12.11 | BAE Systems buy | Citigroup Corp. | |
| 21.12.11 | Barclays outperform | Credit Suisse Group | |
| 21.12.11 | HSBC neutral | Credit Suisse Group | |
| 21.12.11 | AstraZeneca neutral | J.P. Morgan Cazenove | |
| 21.12.11 | GSK neutral | J.P. Morgan Cazenove | |
| 21.12.11 | Vodafone Group outperform | Macquarie Research | |
| 21.12.11 | Barclays neutral | Exane-BNP Paribas SA | |
| 21.12.11 | Lloyds Banking Group underperform | Exane-BNP Paribas SA | |
| 21.12.11 | HSBC outperform | Exane-BNP Paribas SA | |
| 21.12.11 | AstraZeneca reduce | Nomura |